| 书目名称 | Tumor Targeting in Cancer Therapy | | 编辑 | Michel Pagé | | 视频video | | | 概述 | Includes supplementary material: | | 丛书名称 | Cancer Drug Discovery and Development | | 图书封面 |  | | 描述 | After many years of vigorous effort, the use of antibodies to target tumors has become highly successful both clinically and commercially. In Tumor Targeting in Cancer Therapy, Dr. Michel Pagé and a panel of authoritative experts from the drug industry, clinics, and academia introduce the principles and techniques of tumor targeting and critically survey their applications from laboratory to bedside. By concisely synthesizing the many technical details, the authors illuminate this innovative technique, ranging from the fundamentals of drug targeting and in vivo and in vitro experimentation, to such emerging therapeutic uses as radioimmunotherapy, radioimmunodetection, therapy with cytotoxic antibodies, immunotoxins, enzyme prodrug immunotherapy, and immunotherapeutics with fusion proteins. There are also reviews of targeting tumors with radioimmunoconjugates, photodynamic therapy, and magnetic drugs, as well as discussions of the internalization of antibodies, bioconjugation and biodistribution, the use of cytotoxic drugs, and the pros and cons of targeting by antibody or ligand..Comprehensive and practical, Tumor Targeting in Cancer Therapy summarizes the essentials of tumor targe | | 出版日期 | Book 2002 | | 关键词 | antibody-targeted chemotherapy; cancer; cancer therapy; chemistry; chemotherapy; drug; drug resistance; imm | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-59259-167-1 | | isbn_softcover | 978-1-61737-251-3 | | isbn_ebook | 978-1-59259-167-1Series ISSN 2196-9906 Series E-ISSN 2196-9914 | | issn_series | 2196-9906 | | copyright | Springer Science+Business Media New York 2002 |
The information of publication is updating
|
|
发表于 2025-3-21 19:52:45
